Goldman Sachs (GS.N) is in talks to buy a large group of company stakes being sold by asset manager Invesco as it looks to shift illiquid holdings whose value has been hit by the COVID-19 disease outbreak, Sky News reported citing sources.
The holdings are valued at several hundred million pounds, the report said here
A unit of Goldman Sachs Asset Management is close to buying the stakes, which include a holding in Oxford Nanopore, a gene sequencing specialist, according to the report.
Some of the collection of private company holdings were assembled by Neil Woodford, whose flagship fund was winded down last year following a four-and-a-half month suspension, that marked a stunning reversal of fortune for one of Britain’s most high profile investors.
Representatives at Goldman Sachs and Invesco declined to comment.
Source: Reuters
Can’t stop reading? Read more
Fund Friday: Top fundraising news in private equity
Fund Friday: Top fundraising news in private equity Eurazeo has secured €480m, or roughly $567m,...
Blackstone secures regulatory approval to buy stake in India’s Federal Bank
Blackstone secures regulatory approval to buy stake in India’s Federal Bank Blackstone has...
BlackRock folds Aladdin deeper into private markets with unified data platform
BlackRock folds Aladdin deeper into private markets with unified data platform BlackRock is...